ArticleCureus2026
Tranexamic Acid Associated With Reduced Postoperative Transfusion Rates in Hip Fracture Surgery: A Retrospective Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Efficacy and safety of tranexamic acid in patients undergoing hip hemiarthroplasty: an updated systematic review and meta-analysis.Journal of thrombosis and thrombolysis · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims In hip fracture surgery, blood transfusions are common. Allogenic blood transfusions can be associated with adverse effects, and so their use should be reduced where possible. The current study aims to further the knowledge base around the use of tranexamic acid (TXA) in hip fracture surgery patients. This study will focus on outcomes following the use of perioperative TXA in hip fracture patients, with the primary aim of assessing transfusion rates and thromboembolic events. Methods This was a single-centre, retrospective cohort study performed in a high-volume academic trauma unit managing 416 hip fractures per year. Patients undergoing surgery for a hip fracture between August 1, 2019, and August 1, 2020 were included. Two groups, based on whether or not the patient received TXA, were identified. Primary outcomes of interest were transfusion rates, postoperative haemoglobin levels, and the rate of venous thromboembolism (VTE). Results A total of 351 patients were included, 178 in the control group and 173 in the TXA group. On univariate analysis, there were four variables associated with postoperative transfusion: age (RR 1.03, 95% CI 1.01-1.04, p < 0.0001), American Society of Anaesthesiologists (ASA) (RR 1.75, 95% CI 1.35-2.27, p < 0.001), TXA (RR 0.64, 95% CI 0.45-0.94, p = 0.022), and preoperative haemoglobin level (RR 0.93, 95% CI 0.90-0.94, p < 0.0001). On multivariate analysis, both the preoperative haemoglobin (p < 0.0001) and administration of TXA (p = 0.047) were significantly associated with a reduced need for postoperative transfusions. Day 1 haemoglobin levels in the TXA group were significantly higher compared to the no-TXA group (107 g/L, s = 19.9, 95% CI 103.1-109.8 vs 101 g/L, s = 19.2, 95% CI 97.9-104.1, p = 0.0183). With regards to VTE, there was no statistically significant increase in the rate of VTE with the use of TXA for deep venous thrombosis (DVT) (p = 0.242) or pulmonary embolism (PE) (p = 0.242). Conclusion Administering intraoperative TXA is associated with reduced postoperative transfusion rates and improved postoperative haemoglobin levels in hip fracture patients, while not increasing VTE events. Further research in this field should focus on determining an ideal dose, mode of delivery, and timing of TXA administration to optimise its efficacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.